TITLE

Insulin, Insulin-Like Growth Factors and Incretins: Neural Homeostatic Regulators and Treatment Opportunities

AUTHOR(S)
McIntyre, Roger S.; Vagic, Dragana; Swartz, Shari A.; Soczynska, Joanna K.; Woldeyohannes, Hanna O.; Voruganti, Lakshmi P.; Konarski, Jakub Z.
PUB. DATE
April 2008
SOURCE
CNS Drugs;2008, Vol. 22 Issue 6, p443
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Mood disorders may be conceptualized as progressive neurodegenerative disorders associated with cognitive decline. Novel treatments capable of preserving and/or enhancing cognitive function represent an area of priority for research in the future. Insulin, insulin-like growth factor (IGF)-1 and incretins may play a critical role in both physiological and pathophysiological processes of the CNS. An emerging paradigm regarding the pathophysiology of mood disorders posits that alterations in biological networks that mediate stress compromise optimal neuronal and glial function. A growing body of evidence indicates that central administration of insulin may enhance cognitive function in both healthy and cognitively impaired individuals. The neuroactive peptides, insulin, IGF-1 and incretins, or agents that facilitate their central effects (e.g. insulin-sensitizing agents), may constitute novel and possibly disease-modifying neurocognitive treatments.
ACCESSION #
33893488

 

Share

Read the Article

Courtesy of NEW JERSEY STATE LIBRARY

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics